Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine
- PMID: 10992009
Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine
Abstract
Reactive oxygen species are suggested to participate in ischemia-reperfusion (I-R) injury. However, induction of inducible nitric oxide synthase (iNOS) and production of high levels of nitric oxide (NO) also contribute to this injury. NO can combine with superoxide to form the potent oxidant peroxynitrite (ONOO(-)). NO and ONOO(-) were investigated in a rat model of renal I-R injury using the selective iNOS inhibitor L-N(6)-(1-iminoethyl)lysine (L-NIL). Sprague-Dawley rats were subjected to 40 min of bilateral renal ischemia followed by 6 h of reperfusion with or without L-NIL administration. Control animals received a sham surgery and had plasma creatinine values of 0.4 +/- 0.1 mg/dl. I-R surgery significantly increased plasma creatinine levels to 1.9 +/- 0.3 mg/dl (P <.05) and caused renal cortical necrosis. L-NIL administration (3 mg/kg) in animals subjected to I-R significantly decreased plasma creatinine levels to 1.2 +/- 0.10 mg/dl (P <.05 compared with I-R) and reduced tubular damage. ONOO(-) formation was evaluated by detecting 3-nitrotyrosine-protein adducts, a stable biomarker of ONOO(-) formation. Immunohistochemistry and HPLC revealed that the kidneys from I-R animals had increased levels of 3-nitrotyrosine-protein adducts compared with control animals. L-NIL-treated rats (3 mg/kg) subjected to I-R showed decreased levels of 3-nitrotyrosine-protein adducts. These results support the hypothesis that iNOS-generated NO mediates damage in I-R injury possibly through ONOO(-) formation.
Similar articles
-
Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats.J Pharmacol Exp Ther. 1998 Mar;284(3):1139-46. J Pharmacol Exp Ther. 1998. PMID: 9495876
-
Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury.J Surg Res. 2005 Dec;129(2):236-41. doi: 10.1016/j.jss.2005.06.019. Epub 2005 Sep 2. J Surg Res. 2005. PMID: 16140334
-
Proteinuria is reduced by inhibition of inducible nitric oxide synthase in rat renal ischemia-reperfusion injury.Transplant Proc. 2009 Sep;41(7):2907-9. doi: 10.1016/j.transproceed.2009.07.014. Transplant Proc. 2009. PMID: 19765470
-
Nitric oxide in acute renal failure: NOS versus NOS.Kidney Int. 2002 Mar;61(3):855-61. doi: 10.1046/j.1523-1755.2002.00233.x. Kidney Int. 2002. PMID: 11849438 Review.
-
Nitric oxide and renal and cardiac dysfunction in cirrhosis.Clin Sci (Lond). 2002 Feb;102(2):213-22. Clin Sci (Lond). 2002. PMID: 11834141 Review.
Cited by
-
WNT Agonist Decreases Tissue Damage and Improves Renal Function After Ischemia-Reperfusion.Shock. 2015 Mar;43(3):268-75. doi: 10.1097/SHK.0000000000000293. Shock. 2015. PMID: 25514428 Free PMC article.
-
The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester.Mol Cell Biochem. 2005 Sep;277(1-2):165-70. doi: 10.1007/s11010-005-5875-x. Mol Cell Biochem. 2005. PMID: 16132728
-
Carvedilol ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.Biomed Res Int. 2014;2014:105214. doi: 10.1155/2014/105214. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24991534 Free PMC article.
-
Nobiletin Protects from Renal Ischemia-Reperfusion Injury in Rats by Suppressing Inflammatory Cytokines and Regulating iNOS-eNOS Expressions.Inflammation. 2020 Feb;43(1):336-346. doi: 10.1007/s10753-019-01123-w. Inflammation. 2020. PMID: 31705353
-
Inhibiting inducible nitric oxide synthase with rutin reduces renal ischemia/reperfusion injury.Can J Surg. 2013 Feb;56(1):6-14. doi: 10.1503/cjs.004811. Can J Surg. 2013. PMID: 23187035 Free PMC article.